Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

Nestlé to combine its two scientific discovery units to build one impactful organization, Nestlé Research

Vevey, Switzerland, 24-May-2018 — /EuropaWire/ — Nestlé has today announced changes that further strengthen its research and development operations, the largest of any food company worldwide. Nestlé will bring together its two scientific discovery units, the Nestlé Research Center and the … Read the full press release

University of Liverpool researchers awarded £73k grant to help identify brain imaging biomarkers for drug treatment response in epilepsy

LIVERPOOL, 24-May-2018 — /EuropaWire/ — Researchers from the University of Liverpool have been awarded a £73k grant from Epilepsy Research UK to help identify brain imaging biomarkers for drug treatment response in epilepsy. Dr Simon Keller, from the University’s Institute Of Translational Medicine, … Read the full press release

Dupixent demonstrated significant improvement in multiple asthma endpoints in two Phase 3 clinical trials

Results showed Dupixent demonstrated a significant improvement in multiple asthma endpoints in two Phase 3 clinical trials in a broad population of patients with uncontrolled asthma, irrespective of minimum baseline eosinophil levels or other biomarkers of Type 2 inflammation Greater … Read the full press release

University of Nottingham Malaysia researchers discovered new natural compounds from a local fig plant that could lead to improved treatment for resistant hypertension

NOTTINGHAM, 21-May-2018 — /EuropaWire/ — Researchers have discovered new natural compounds in a fig plant species native to Malaysia that could lead to improved treatment for resistant hypertension. Dr Kuan Hon Lim and his team from the University of Nottingham Malaysia have isolated a new class of natural compounds from a local fig plant species that induce vasodilation in aorta tissue, … Read the full press release

GlaxoSmithKline to present comprehensive portfolio of respiratory research and scientific innovation at the American Thoracic Society (ATS) conference

Brentford, United Kingdom, 17-May-2018 — /EuropaWire/ — GlaxoSmithKline plc (GSK) will present extensive data from across its respiratory portfolio, pipeline and early phase research programmes at the American Thoracic Society (ATS) conference in San Diego, USA, 19-23 May 2018. Data presented … Read the full press release

UNIGE and HUG study on 1950s antibiotic treatments against urinary tract infections: Only one is as effective as the newer drugs

Two old drugs for combatting urinary tract infections are being prescribed once more in an attempt to protect newer antibiotics from bacterial resistance, and thus preserve their effectiveness. Only one of these drugs from yesteryear appears to be as effective … Read the full press release

Paul Scherrer Institute PSI inaugurates new treatment unit for proton therapy against cancer

With millimetre precision, certain tumours can be irradiated at the Paul Scherrer Institute PSI using protons – that is, positively charged elementary particles. PSI is the one place in Switzerland where this especially protective and precise option for radiation therapy … Read the full press release

ESC statement on inflammation in atherosclerosis: more evidence needed before anti-inflammatory drugs can join statins as standard treatment

SOPHIA ANTIPOLIS, 15-May-2018 — /EuropaWire/ — A European Society of Cardiology (ESC) consensus statement on inflammation in atherosclerosis is published today in the European Journal of Preventive Cardiology. (1) Written by the ESC Working Group on Atherosclerosis and Vascular Biology, the document … Read the full press release

Novartis division Sandoz receives US FDA complete response letter regarding the Biologics Licensing Application for its proposed biosimilar rituximab

Holzkirchen, Germany, 04-May-2018 — /EuropaWire/ — Sandoz, a Novartis division, announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the Biologics Licensing Application (BLA) for its proposed biosimilar rituximab. Sandoz stands behind … Read the full press release

Novartis: Today’s FDA approval of Kymriah provides another opportunity for Novartis to build on its leadership in CAR-T development

Kymriah demonstrated an overall response rate of 50%, with median duration of response not yet reached at the time of data cut-off, indicating sustainability of response[1] Kymriah is the only CAR-T therapy FDA-approved for two distinct indications – in non-Hodgkin … Read the full press release

Chinese Patent Office issued patent for Merck’s CRISPR technology used in a genomic-integration method for eukaryotic cells

Merck today (23 APR 2018) announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells. Patent in China covers integration of an external … Read the full press release

John C. Reed, M.D. Ph.D. to succeed Elias Zerhouni, M.D. as Head of Global Research and Development at Sanofi

PARIS, 25-Apr-2018 — /EuropaWire/ — Elias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the post … Read the full press release

Heinrich Heine University, Henkel: milestone based on the Phenion® skin model has been reached in skin ageing research

Phenion: An innovative testing system for skin ageing research Düsseldorf, Germany, 24-Apr-2018 — /EuropaWire/ — The Phenion® Full Thickness Skin Model developed by Henkel scientists is e.g. known, for its application in the “3D Skin Comet assay”. This validated method allows the … Read the full press release

TU Delft: Researchers created an artificial DNA blueprint for the replication of DNA in a cell-like structure

Researchers at Delft University of Technology, in collaboration with colleagues at the Autonomous University of Madrid, have created an artificial DNA blueprint for the replication of DNA in a cell-like structure. Creating such a complex biological module is an important … Read the full press release

Wacker Chemie AG to acquire Dutch site for manufacturing biopharmaceuticals, live microbial products and vaccines from SynCo Bio Luxembourg S.à.r.l.

WACKER TAKES OVER SYNCO BIO PARTNERS OF AMSTERDAM CAPACITY OF ACQUIRED FERMENTATION PLANT FOR PHARMACEUTICAL ACTIVES TOTALS SOME 2,000 LITERS – WACKER BIOTECH’S OVERALL CAPACITY DOUBLES AS A RESULT SYNCO’S EXPERTISE IN MANUFACTURING LIVE MICROBIAL PRODUCTS AND IN FILLING FINISHED … Read the full press release

Kevin Sin appointed new SVP and Head of Worldwide Business Development for R&D at GSK

Critical role appointed as part of ongoing activities to strengthen and accelerate the Pharmaceuticals pipeline LONDON, 20-Apr-2018 — /EuropaWire/ — GlaxoSmithKline plc (GSK) today announced the appointment of Kevin Sin as Senior Vice President and Head of Worldwide Business Development for … Read the full press release

GlaxoSmithKline, Innoviva: Landmark IMPACT study shows significant benefits of Trelegy Ellipta for patients with chronic obstructive pulmonary disease (COPD)

LONDON, 20-Apr-2018 — /EuropaWire/ — Once-daily single inhaler triple therapy superior to Relvar/Breo Ellipta and Anoro Ellipta across multiple endpoints including exacerbations, lung function and quality of life. GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the … Read the full press release

Roche: US FDA granted Breakthrough Therapy Designation to Hemlibra® for people with haemophilia A without factor VIII inhibitors

Designation based on phase III HAVEN 3 study demonstrating Hemlibra prophylaxis significantly reduced bleeds compared to no prophylaxis First medicine to show superior efficacy compared to prior factor VIII prophylaxis in an intra-patient comparison BASEL, 19-Apr-2018 — /EuropaWire/ — Roche … Read the full press release

KTH researchers produced microparticles with encapsulated cells that can be used as implants to fight cancer, diabetes or heart disease

STOCKHOLM, 18-Apr-2018 — /EuropaWire/ — One way that cancer may be fought in the future is with micro-sized capsules containing living cells engineered to secrete toxins that attack cancer cells. Although the science of cell micro-encapsulation has yet to overcome certain … Read the full press release

Sanova Pharma GesmbH and Ökopharm GmbH form strategic partnership

Sanova Pharma GesmbH (“Sanova”) and Ökopharm GmbH, two leading Austrian consumer healthcare companies, signed a definitive agreement for a strategic partnership and the acquisition of Ökopharm’s core products. The acquisition is subject to certain closing conditions, including approval by the … Read the full press release

McKesson Europe subsidiary OCP acquires PHR group

OCP, a subsidiary of McKesson Europe, a European distributor of healthcare products and a pharmaceutical retailer, has acquired the PHR group, a major player in pharmacist groups in France. STUTTGART, 12-Apr-2018 — /EuropaWire/ — At a time when all the players … Read the full press release

UZH: new crystallographic method is set to greatly accelerate drug development

ZURICH, 27-Mar-2018 — /EuropaWire/ — UZH researchers have developed a novel method that speeds up the process of determining crystal structures of organic salts and significantly reduces the effort required to do so. As about 40 percent of all active pharmaceutical … Read the full press release

Sandoz: EMA Committee for Medicinal Products for Human Use (CHMP) adopts positive opinion for marketing authorization of infliximab

Sandoz is seeking approval of biosimilar infliximab for use in all indications of its reference medicine across gastroenterology, rheumatology and dermatology Positive opinion is based on comprehensive clinical and non-clinical data that is expected to confirm that Sandoz biosimilar infliximab … Read the full press release

Kuehne + Nagel extends overland pharma cross dock platform in Contern, Luxembourg

Extension of the European overland pharma cross dock platform in Luxembourg for more frequent departures and faster transit times Complete coverage to all European destinations Enhanced real time monitoring solutions for temperature sensitive pharma shipments Contern, Luxembourg, 26-Mar-2018 — /EuropaWire/ … Read the full press release

GSK: We are delighted to start the phase III study and evolve our research programme for belimumab in systemic lupus erythematosus (SLE)

LONDON, 22-Mar-2018 — /EuropaWire/ — GSK today announced the start of a phase III study investigating Benlysta (belimumab) in combination with rituximab in adult patients with systemic lupus erythematosus (SLE). Belimumab and rituximab have different but potentially complementary mechanisms of action. … Read the full press release

Roche: Phase III IMpower131 study met its co-primary endpoint of progression-free survival of people with a type of advanced squamous lung cancer

BASEL, 20-Mar-2018 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane [albumin-bound … Read the full press release

H. Lundbeck A/S to acquire Prexton Therapeutics BV for EUR 100 million upfront and up to EUR 805 million in development and sales milestones paid later

Lundbeck will make an upfront payment of EUR 100 million and the deal terms also include up to EUR 805 million in development, regulatory and sales milestones Foliglurax is a first-in-class treatment which entered clinical phase II testing in Parkinson’s … Read the full press release

Alliance Life Sciences is a Sponsor at World Pharma Pricing and Market Access Congress 2018, Showcasing Data and Technology Solutions

World Pharma Pricing and Market Access Congress 2018 Business Design Centre, London United Kingdom SOMERSET, N.J. / LONDON, UK, 19-Mar-2018 — /EuropaWire/ — Alliance Life Sciences, a leading global life sciences consulting, pricing data and technology provider, announced that it is … Read the full press release

Diabetes: US FDA approval for Medtronic’s Guardian(TM) Connect continuous glucose monitoring (CGM) system

 ‘Smart’ CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management DUBLIN, 13-Mar-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received … Read the full press release

Medtronic plc now accepts applications for the 2018 Medtronic Global Champions team

Medtronic Seeks Up to 20 Runners Who Benefit from Medical Technology Selected Runners Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October 2018 Applications Accepted at www.medtronic.com/globalchampions DUBLIN, 13-Mar-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), … Read the full press release